Eli Lilly (LLY) Capital Expenditures (2009 - 2025)
Eli Lilly (LLY) posted Capital Expenditures of $3.18 billion for Q3 2026, up 52.3% from $2.09 billion a year earlier and up 8.4% from the prior quarter.
Powered by 
Analysis
Eli Lilly (LLY) Capital Expenditures (2009 - 2025) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Capital Expenditures at Eli Lilly was $10.98 billion, up 61.8% year-over-year; for FY2025, it was $7.84 billion, up 55.0% from FY2024.
- Annual Capital Expenditures has increased for four consecutive years, with a five-year compound annual growth rate of 41.4% (FY2020 to FY2025).
- In prior years, Eli Lilly's Capital Expenditures was $5.06 billion in FY2024 (+46.7%), $3.45 billion in FY2023 (+85.9%), $1.85 billion in FY2022 (+41.6%) and $1.31 billion in FY2021 (-5.6%).
- The Q3 2026 figure stands as the highest quarterly Capital Expenditures in data going back to Q1 2009.
- On a year-over-year basis, Capital Expenditures has increased in each of the last 17 quarters, with growth averaging 54.4% over the last eight quarters.
- The strongest year-over-year quarter for Capital Expenditures in the past five years was Q4 2023, with growth of 113.9%; the weakest was Q4 2021, with a decline of 35.9%.
- According to Business Quant data, Capital Expenditures for the three prior quarters was $2.93 billion (Q2 2026), $2.33 billion (Q1 2026) and $2.55 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Yr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 7.84 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 4.83 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.21 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.11 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 1.55 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 2.81 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 1.86 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 563.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 2.63 Bn |
| 10 | Vertex Pharmaceuticals | 138.90 Bn | 106.64 Bn | 2.91 Bn | 437.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 7.84 Bn |
| Dec 31, 2024 | 5.06 Bn |
| Dec 31, 2023 | 3.45 Bn |
| Dec 31, 2022 | 1.85 Bn |
| Dec 31, 2021 | 1.31 Bn |
| Dec 31, 2020 | 1.39 Bn |
| Dec 31, 2019 | 1.03 Bn |
| Dec 31, 2018 | 1.21 Bn |
| Dec 31, 2017 | 1.08 Bn |
| Dec 31, 2016 | 1.04 Bn |
| Dec 31, 2015 | 1.07 Bn |
| Dec 31, 2014 | 1.16 Bn |
| Dec 31, 2013 | 1.01 Bn |
| Dec 31, 2012 | 905.40 Mn |
| Dec 31, 2011 | 672.00 Mn |
| Dec 31, 2010 | 694.30 Mn |
| Dec 31, 2009 | 765.00 Mn |
API Access
Eli Lilly Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures-annual&ticker=LLY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures-annual", "ticker": "LLY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures-annual&ticker=LLY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();